Penetration of cefuroxime and ceftazidime into human lungs. 1988

E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
Department of Microbiology, University Hospital, Seville, Spain.

We have studied the penetration of cefuroxime and ceftazidime into lung tissue of 40 patients subjected to pulmonary surgery. Samples of blood and lung tissue were taken 1 and 2 h after antibiotic administration. Patients were randomly assigned to four dosage schedule groups: group A received a single intravenous injection of 750 mg cefuroxime; the lung tissue levels at 1 and 2 h were 9.6 +/- 3.1 and 4.54 +/- 2.64 micrograms/g of cefuroxime; the percentage penetration from serum into the lung tissue was 33.7 and 34.6%, respectively. Group B patients received three doses of 750 mg cefuroxime; lung tissue levels were 17.1 +/- 7.7 and 14.7 +/- 5.4 micrograms/g, the percentage of penetration being 89.1 and 102.8% at 1 and 2 h. Group C received a single intravenous injection of 1 g ceftazidime; the lung tissue levels were 16.3 +/- 10.1 and 10 +/- 5.04 micrograms/g; the percentage of penetration from serum was 38.3 and 35.3%. Group D received three doses of 1 g ceftazidime; the lung tissue concentrations were 11.98 +/- 7.5 and 8.5 +/- 7.3 micrograms/g and the percentage of penetration 35.1 and 32.2% at 1 and 2 h after last dose.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D002444 Cefuroxime Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS. Cephuroxime,Ketocef,Zinacef
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
January 1993, Infection,
E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
January 1981, Arzneimittel-Forschung,
E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
January 1985, Scandinavian journal of infectious diseases. Supplementum,
E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
January 1997, Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde,
E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
February 1990, The Journal of antimicrobial chemotherapy,
E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
September 1989, The Journal of antimicrobial chemotherapy,
E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
May 1987, Lancet (London, England),
E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
April 1991, The Journal of antimicrobial chemotherapy,
E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
September 1981, The Journal of antimicrobial chemotherapy,
E J Perea, and J Ayarra, and M C García Iglesias, and I García Luque, and J Loscertales
July 1983, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!